• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环肿瘤细胞及其与神经内分泌肿瘤患者骨转移的关联。

Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours.

机构信息

Department of Oncology, UCL Cancer Institute, University College London, London, UK.

Department of Pathology, UCL Cancer Institute, University College London, London, UK.

出版信息

Br J Cancer. 2019 Feb;120(3):294-300. doi: 10.1038/s41416-018-0367-4. Epub 2019 Jan 14.

DOI:10.1038/s41416-018-0367-4
PMID:30636773
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6353867/
Abstract

BACKGROUND

Bone metastases are associated with a worse outcome in patients with neuroendocrine tumours (NETs). Tumour overexpression of C-X-C chemokine receptor 4 (CXCR4) appears predictive of skeletal involvement. We investigated the role of circulating tumour cells (CTCs) and CXCR4 expression on CTCs as potential predictors of skeleton invasion.

METHODS

Blood from patients with metastatic bronchial, midgut or pancreatic NET (pNET) was analysed by CellSearch. CXCR4 immunohistochemistry was performed on matched formalin-fixed paraffin-embedded (FFPE) samples.

RESULTS

Two hundred and fifty-four patients were recruited with 121 midgut and 119 pNETs, of which 51 and 36% had detectable CTCs, respectively. Bone metastases were reported in 30% of midgut and 23% of pNET patients and were significantly associated with CTC presence (p = 0.003 and p < 0.0001). In a subgroup of 40 patients, 85% patients with CTCs had CTCs positive for CXCR4 expression. The proportion of CXCR4-positive CTCs in patients with bone metastases was 56% compared to 35% in those without (p = 0.18) it. Staining for CXCR4 on matched FFPE tissue showed a trend towards a correlation with CXCR4 expression on CTCs (p = 0.08).

CONCLUSIONS

CTC presence is associated with bone metastases in NETs. CXCR4 may be involved in CTC osteotropism and present a therapeutic target to reduce skeletal morbidity.

摘要

背景

骨转移与神经内分泌肿瘤(NET)患者的预后较差相关。肿瘤过度表达 C-X-C 趋化因子受体 4(CXCR4)似乎预示着骨骼受累。我们研究了循环肿瘤细胞(CTC)的作用和 CTC 上的 CXCR4 表达作为骨骼侵犯的潜在预测因子。

方法

通过 CellSearch 分析转移性支气管、中肠或胰腺 NET(pNET)患者的血液。对匹配的福尔马林固定石蜡包埋(FFPE)样本进行 CXCR4 免疫组织化学染色。

结果

共招募了 254 名患者,其中 121 名患有中肠 NET,119 名患有 pNET,分别有 51%和 36%的患者可检测到 CTC。30%的中肠和 23%的 pNET 患者报告有骨转移,且与 CTC 存在显著相关(p=0.003 和 p<0.0001)。在 40 名患者的亚组中,85%的 CTC 阳性患者的 CTC 表达 CXCR4。有骨转移的患者中 CXCR4 阳性 CTC 的比例为 56%,而无骨转移的患者为 35%(p=0.18)。对匹配的 FFPE 组织进行 CXCR4 染色显示与 CTC 上的 CXCR4 表达呈趋势相关(p=0.08)。

结论

CTC 的存在与 NET 中的骨转移相关。CXCR4 可能参与 CTC 的成骨趋向性,并提供减少骨骼发病率的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e13c/6353867/3cba95f6c662/41416_2018_367_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e13c/6353867/667be23c92ed/41416_2018_367_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e13c/6353867/7ae0181ff85d/41416_2018_367_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e13c/6353867/3cba95f6c662/41416_2018_367_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e13c/6353867/667be23c92ed/41416_2018_367_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e13c/6353867/7ae0181ff85d/41416_2018_367_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e13c/6353867/3cba95f6c662/41416_2018_367_Fig3_HTML.jpg

相似文献

1
Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours.循环肿瘤细胞及其与神经内分泌肿瘤患者骨转移的关联。
Br J Cancer. 2019 Feb;120(3):294-300. doi: 10.1038/s41416-018-0367-4. Epub 2019 Jan 14.
2
Circulating tumor cells and EpCAM expression in neuroendocrine tumors.循环肿瘤细胞和神经内分泌肿瘤中的 EpCAM 表达。
Clin Cancer Res. 2011 Jan 15;17(2):337-45. doi: 10.1158/1078-0432.CCR-10-1776. Epub 2011 Jan 11.
3
Prognostic Threshold for Circulating Tumor Cells in Patients With Pancreatic and Midgut Neuroendocrine Tumors.循环肿瘤细胞对胰腺和中肠神经内分泌肿瘤患者预后的预测价值。
J Clin Endocrinol Metab. 2021 Mar 8;106(3):872-882. doi: 10.1210/clinem/dgaa822.
4
CXCR4-SDF-1 interaction potentially mediates trafficking of circulating tumor cells in primary breast cancer.CXCR4与SDF-1的相互作用可能介导原发性乳腺癌中循环肿瘤细胞的转运。
BMC Cancer. 2016 Feb 19;16:127. doi: 10.1186/s12885-016-2143-2.
5
Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients.转移性去势抵抗性前列腺癌患者骨转移和循环肿瘤细胞的基因表达分析
J Transl Med. 2016 Mar 15;14:72. doi: 10.1186/s12967-016-0829-5.
6
Somatostatin and chemokine CXCR4 receptor expression in pancreatic adenocarcinoma relative to pancreatic neuroendocrine tumours.生长抑素与趋化因子 CXCR4 受体在胰腺腺癌与胰腺神经内分泌肿瘤中的表达。
J Cancer Res Clin Oncol. 2019 Oct;145(10):2481-2493. doi: 10.1007/s00432-019-03011-0. Epub 2019 Aug 26.
7
Reviewing the Osteotropism in Neuroendocrine Tumors: The Role of Epithelial-Mesenchymal Transition.神经内分泌肿瘤中的骨嗜性研究:上皮-间质转化的作用
Neuroendocrinology. 2016;103(3-4):321-34. doi: 10.1159/000438902. Epub 2015 Jul 28.
8
Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study.循环肿瘤细胞和CXCR4表达作为CXCR4肽拮抗剂联合卡铂-依托泊苷治疗小细胞肺癌生物标志物的预后和预测价值:一项II期研究的探索性分析
Invest New Drugs. 2017 Jun;35(3):334-344. doi: 10.1007/s10637-017-0446-z. Epub 2017 Mar 15.
9
Dynamics of CXCR4 positive circulating tumor cells in prostate cancer patients during radiotherapy.在放疗期间前列腺癌患者 CXCR4 阳性循环肿瘤细胞的动力学。
Int J Cancer. 2023 Jun 15;152(12):2639-2654. doi: 10.1002/ijc.34457. Epub 2023 Mar 13.
10
Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients.检测转移性乳腺癌患者循环肿瘤细胞中的雄激素受体状态。
BMC Cancer. 2019 Nov 12;19(1):1101. doi: 10.1186/s12885-019-6323-8.

引用本文的文献

1
Biomarker-Driven Approaches to Bone Metastases: From Molecular Mechanisms to Clinical Applications.生物标志物驱动的骨转移治疗方法:从分子机制到临床应用
Biomedicines. 2025 May 10;13(5):1160. doi: 10.3390/biomedicines13051160.
2
Stem cell-like circulating tumor cells identified by Pep@MNP and their clinical significance in pancreatic cancer metastasis.通过Pep@MNP鉴定的干细胞样循环肿瘤细胞及其在胰腺癌转移中的临床意义。
Front Oncol. 2024 Jun 25;14:1327280. doi: 10.3389/fonc.2024.1327280. eCollection 2024.
3
Circulating Tumour Cells in the Prediction of Bone Metastasis.

本文引用的文献

1
Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative Approach.神经内分泌肿瘤中趋化因子受体4表达的成像——一种三示踪剂对比方法
Theranostics. 2017 Apr 5;7(6):1489-1498. doi: 10.7150/thno.18754. eCollection 2017.
2
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.美国神经内分泌肿瘤患者的发病率、患病率和生存结局趋势。
JAMA Oncol. 2017 Oct 1;3(10):1335-1342. doi: 10.1001/jamaoncol.2017.0589.
3
Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study.
循环肿瘤细胞在骨转移预测中的作用
Cancers (Basel). 2024 Jan 5;16(2):252. doi: 10.3390/cancers16020252.
4
The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective.神经内分泌肿瘤循环生物标志物的探索:临床视角
Curr Treat Options Oncol. 2023 Dec;24(12):1833-1851. doi: 10.1007/s11864-023-01147-3. Epub 2023 Nov 22.
5
Role of Selected Circulating Tumor Biomarkers in Patients with Skeletal Metastatic Pancreatic Neuroendocrine Neoplasms.特定循环肿瘤生物标志物在骨骼转移性胰腺神经内分泌肿瘤患者中的作用
J Clin Med. 2023 Jul 14;12(14):4687. doi: 10.3390/jcm12144687.
6
Circulating biomarkers for diagnosis and therapeutic monitoring in bone metastasis.循环生物标志物在骨转移中的诊断和治疗监测。
J Bone Miner Metab. 2023 May;41(3):337-344. doi: 10.1007/s00774-022-01396-6. Epub 2023 Feb 2.
7
Risk Stratification of Pancreatic Neuroendocrine Neoplasms Based on Clinical, Pathological, and Molecular Characteristics.基于临床、病理和分子特征的胰腺神经内分泌肿瘤风险分层
J Clin Med. 2022 Dec 15;11(24):7456. doi: 10.3390/jcm11247456.
8
Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies.晚期胰腺神经内分泌肿瘤患者接受药物/放射/肝脏靶向抗肿瘤治疗后耐药性疾病的预测因素:最新进展与争议
Cancers (Basel). 2022 Feb 28;14(5):1250. doi: 10.3390/cancers14051250.
9
Current and New Challenges in the Management of Pancreatic Neuroendocrine Tumors: The Role of miRNA-Based Approaches as New Reliable Biomarkers.当前和新的挑战在管理胰腺神经内分泌肿瘤: miRNA 为基础的方法的作用作为新的可靠的生物标志物。
Int J Mol Sci. 2022 Jan 20;23(3):1109. doi: 10.3390/ijms23031109.
10
Predicting Bone Metastasis Using Gene Expression-Based Machine Learning Models.使用基于基因表达的机器学习模型预测骨转移
Front Genet. 2021 Nov 10;12:771092. doi: 10.3389/fgene.2021.771092. eCollection 2021.
循环肿瘤细胞和CXCR4表达作为CXCR4肽拮抗剂联合卡铂-依托泊苷治疗小细胞肺癌生物标志物的预后和预测价值:一项II期研究的探索性分析
Invest New Drugs. 2017 Jun;35(3):334-344. doi: 10.1007/s10637-017-0446-z. Epub 2017 Mar 15.
4
Osteotropism of neuroendocrine tumors: role of the CXCL12/ CXCR4 pathway in promoting EMT in vitro.神经内分泌肿瘤的骨嗜性:CXCL12/CXCR4 通路在体外促进上皮-间质转化中的作用
Oncotarget. 2017 Apr 4;8(14):22534-22549. doi: 10.18632/oncotarget.15122.
5
Expression of somatostatin receptors 2 and 5 in circulating tumour cells from patients with neuroendocrine tumours.神经内分泌肿瘤患者循环肿瘤细胞中生长抑素受体2和5的表达
Br J Cancer. 2016 Dec 6;115(12):1540-1547. doi: 10.1038/bjc.2016.377. Epub 2016 Nov 22.
6
The epidemiology of metastases in neuroendocrine tumors.神经内分泌肿瘤转移的流行病学
Int J Cancer. 2016 Dec 15;139(12):2679-2686. doi: 10.1002/ijc.30400. Epub 2016 Sep 9.
7
CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR.CXCR4/CXCL12/CXCR7轴在神经内分泌肿瘤中发挥作用,并作用于mTOR发出信号。
Oncotarget. 2016 Apr 5;7(14):18865-75. doi: 10.18632/oncotarget.7738.
8
Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway.乌洛库单抗(BMS-936564 / MDX1338):一种完全人源化抗CXCR4抗体,通过活性氧依赖性途径介导慢性淋巴细胞白血病细胞死亡。
Oncotarget. 2016 Jan 19;7(3):2809-22. doi: 10.18632/oncotarget.6465.
9
Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy.生长抑素与CXCR4趋化因子受体在不同恶性程度的胃肠胰神经内分泌肿瘤中的反向表达
Oncotarget. 2015 Sep 29;6(29):27566-79. doi: 10.18632/oncotarget.4491.
10
Reviewing the Osteotropism in Neuroendocrine Tumors: The Role of Epithelial-Mesenchymal Transition.神经内分泌肿瘤中的骨嗜性研究:上皮-间质转化的作用
Neuroendocrinology. 2016;103(3-4):321-34. doi: 10.1159/000438902. Epub 2015 Jul 28.